1264. Assessment of In Vivo Efficacy of CF-296 in addition to Vancomycin (VAN) and Daptomycin (DAP) against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model

BACKGROUND: CF-296 is a novel lysin in pre-clinical development for the treatment of methicillin-susceptible and methicillin-resistant Staphylococcus aureus infections, used in addition to standard of care antibiotics including VAN and DAP. We evaluated the in vivo efficacy of CF-296 alone and in ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Asempa, Tomefa E, DeRosa, Nicole A, Cassino, Cara, Lehoux, Dario, Schuch, Raymond, Nicolau, David P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777438/
http://dx.doi.org/10.1093/ofid/ofaa439.1448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777438/
http://dx.doi.org/10.1093/ofid/ofaa439.1448

Ejemplares similares